Fundraising FoxBoston Millennia Partners
Venture capitalBoston · Seed–Late Stage · 8 people tracked
Also known as GLEN VENTURES MANAGMENT, INC
Find your way into Boston Millennia Partners
Sign up to see every warm intro you have to Boston Millennia Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Boston Millennia Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Boston Millennia Partners is a private equity firm that invests in healthcare and life sciences companies.
Source: firm website, verified Jul 28, 2026.
Team · 8 people
from curated & public directories
What they invest in
from 10 of 11 portfolio companiesAI & Machine Learning ×7Healthtech ×7Digital Health ×4Enterprise Software ×4Medical Devices ×4SaaS ×3Biotech ×2HR Tech ×1
HQs:United States×9
Investments · 11 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 12023 · 12021 · 12018 · 16 dated
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions.
BiotechCanton, US
Michael Heffernan(Executive Officer, Director)inPaul Brannelly(Executive Officer)inVikram Karnani(President and Chief Executive Officer, and Director)in
BoardEran Nadav(Director)John Freund(Director)Patrick Heron(Director)in
Co-investorsAPERTURE Venture PartnersEcoR1 CapitalFrazier Life SciencesLongitude CapitalRA Capital
HRSoft is a provider of enterprise compensation management software that enables organizations to design, manage, and automate complex pay programs including merit, bonus, equity, and incentive plans.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechMedical DevicesSaaSPhiladelphia, US
Joe Poxson(Chief Executive Officer)
Co-investorsExcelerate Health VenturesRobin Hood VenturesStrattech Partners, LLCTech Council Ventures
BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.
AI & Machine LearningDigital HealthHealthtechBranford, US
Joshua Ransom(Executive Officer)David Levin(Chief Executive Officer)inJosh Brown(Chief Technology Officer)inScott Caflisch(Chief Information Security Officer)inJeff Graham(Chief Data Officer)inJennifer Stacey(Chief Operating Officer)in
Co-investorsConnecticut InnovationsExcelerate Health VenturesHatteras Venture PartnersMartin VenturesSopris Venture Capital
Hyperion Biosystems builds diagnostic devices that use computer vision and physics-based algorithms to improve the sensitivity and specificity of point-of-care and at-home tests.
AI & Machine LearningHealthtechMedical Devices
Co-investorsNewlin Investment Company LLCSafar PartnersBreakout LabsCranberry CapitalPropel Venture PartnersThe Engine Ventures
Korio provides RTSM (Randomization and Trial Supply Management) software for clinical trials, with a focus on experienced project management and continuity throughout the study lifecycle.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSDoylestown, US
Ryan Keane(Executive Officer, Director)inChuck Harris(Executive Officer, Director)in
BoardAustin Poole(Director)Hugh R. Roome(Director)B. Bobby Bahram(Director)in
Co-investorsBIP VenturesExcelerate Health VenturesFirst Trust Capital Partners
Odyssey Logistics provides managed transportation and supply chain solutions tailored to complex industries, operating multimodal logistics divisions including integrated marine logistics and transport & warehouse services.
AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainCharlotte, US
Robert Shellman(Executive Officer, Director)Raymond Maier(Executive Officer)inCosmo Alberico(Executive Officer)inRichard McEvoy(Executive Officer)Ravi Tulsyan(Chief Financial Officer)Maneet Singh(Chief Information Officer)
Co-investorsRRE Ventures
Reveleer provides a unified platform combining AI-powered retrieval, clinical intelligence, risk adjustment, and quality improvement tools for healthcare providers and health plans operating under value-based care models.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtech
Co-investorsOak HC/FTTHL FUNDUpfront VenturesHercules Capital, Inc.
S2N Health provides commercial intelligence, analytics, and go-to-market strategy services for medtech, diagnostics, digital health, and drug delivery companies, from startups to global enterprises.
AI & Machine LearningHealthtechMedical DevicesSales TechBoston, US
Amy Siegel(CEO & Co-Founder)inTim Kofol(CTO & Co-Founder)inLeah Shea(Chief Product Officer)in
BoardRoome Hugh(Director)Andrew Schwab(Director)inMartha Shadan(Director)in
Co-investorsExcelerate Health VenturesRittenhouse VenturesRobin Hood Ventures
Xevant offers an automated data analytics and reporting platform for pharmacy benefit organizations, using AI to standardize diverse data formats, analyze pharmacy claims, and generate reports and repricing outputs.
AI & Machine LearningDigital HealthSaaSLehi, US
Brandon Newman(CEO)inPETE TANTILLO(Executive Officer)JEFF LININGER(Executive Officer)DANIEL TELFORD(Executive Officer)DON DEGOYLER(Director)NICK CONWAY(Director)
Co-investorsHCAP PartnersTech Council VenturesMartinson VenturesTCV
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsCollegium PharmaceuticalNASDAQ: COLL
Portfolio news
latest coverage across their companiesS2N Health · s2nhealth.com · Aug 11, 2025
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Collegium Pharmaceutical | 4.6% | $20.00 | Jan 2016 | $21.6M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Boston Millennia Partners made?
- Boston Millennia Partners has 11 tracked investments, 1 of which have exited, including 2 dated in the last 24 months.
- What stage does Boston Millennia Partners invest at?
- Boston Millennia Partners invests at the Seed, Growth, Late Stage stages.
- What is Boston Millennia Partners's typical check size?
- Boston Millennia Partners typically writes checks of $3M – $5M.
- What sectors does Boston Millennia Partners focus on?
- Boston Millennia Partners focuses on Biotech, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Boston Millennia Partners located?
- Boston Millennia Partners is headquartered in Boston, US.
Similar investors
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
SMBC Venture Capital is a Japanese venture capital firm and a member of Sumitomo Mitsui Financial Group (SMBC Group), with over 20 years of investing experience. It leverages the group's network of auditors, securities firms, and other investors to support startups.